The Asian Health Foundation announces a free toolkit for HCPs treating liver disease in AAPI populations

I'll B There: Hepatitis B in Our Community

Produced by the Asian Health Foundation, and supported by an independent educational grant from Gilead Sciences, Inc.

AAPIs comprise ~50% of CHB cases, but only comprise 6% of the population in the U.S.

Chronic hepatitis B virus (CHB) is often called a “silent killer” because people may have no symptoms and are unaware that they are infected, over many years, until developing serious liver disease, liver failure, or liver cancer.

In the United States, Asian Americans and Paciﬁc Islanders (AAPIs) are disproportionately impacted by CHB, with approximately half of the cases while comprising only 6% of the population. CHB is the leading cause of liver cancer for Asian Americans. In addition, delays in identifying disease status can result in an increased probability of virus transmission to others, limited treatment options, and poorer patient outcomes.

Although there is currently no cure, vaccines for preventing hepatitis B and effective treatments for patients who have hepatitis B are available.

However, there is an alarmingly low level of understanding and knowledge of hepatitis B in the AAPI population and healthcare provider community.

About the I'll Be There Toolkit

Help raise awareness in patients who are at-risk for hepatitis B.

Produced by the Asian Health Foundation, and supported by an independent educational grant from Gilead Sciences, Inc., the I'll B There Toolkit was created to address this health disparity by educating Asian American patients about hepatitis B, including who's at risk; the importance of preventive measures, screening, and diagnosis; and linkage to care, medication adherence and continued surveillance for those with chronic hepatitis B.

Patient Video

A video featuring interviews of patients with hepatitis B—together with graphics and commentary by faculty/HBV clinician experts—provides informative and engaging content to personalize these messages in the settings of authenticity, experience, and cultural relevance. Their stories are an informative and compelling call-to-action for patients to be screened for HBV, vaccinated, monitored or treated, after consulting with their healthcare providers.

Screening for CHB Poster

The Toolkit also contains an educational poster, designed for display in ofﬁces of health care providers with information about CHB. The overarching message is for Asian Americans and Paciﬁc Islanders to know their hepatitis B status through screening and the importance of treatment so that they can take care of themselves and “B There” for their families.

Posters provided in English, Simplified Chinese, Korean, and Vietnamese

Request your free toolkit

To receive a toolkit, click the button above and request your copy by email. Kits are mailed via United States Postal Service.

The I’ll B There patient video is also accessible online.
Click here to view.